428 results match your criteria: "American College of Cardiology[Affiliation]"
JACC Adv
January 2025
American College of Cardiology, Washington, DC, USA.
A total of 9 million veterans receive care in a unique healthcare system, the Veterans Healthcare Administration (VHA), with nearly 50% reporting at least one cardiovascular disease. Despite evidence for high quality of health care in the VHA, more veteran care is being moved to the non-VHA community. An assumption of this shift in care is that the quality of non-VHA care is at least comparable to VHA care.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
January 2025
Division of Cardiology Lifespan Cardiovascular Institute, Warren Alpert Medical School of Brown University, Providence, RI (J.D.A.).
Background: In-hospital mortality risk prediction is an important tool for benchmarking quality and patient prognostication. Given changes in patient characteristics and treatments over time, a contemporary risk model for patients with acute myocardial infarction (MI) is needed.
Methods: Data from 313 825 acute MI hospitalizations between January 2019 and December 2020 for adults aged ≥18 years at 784 sites in the National Cardiovascular Data Registry Chest Pain-MI Registry were used to develop a risk-standardized model to predict in-hospital mortality.
Circ Cardiovasc Qual Outcomes
January 2025
Scientific Publications Committee, American College of Cardiology, Washington, DC (J.A.B.).
JACC Adv
January 2025
Sanger Heart and Vascular Institute/Atrium Health, Charlotte, North Carolina, USA.
Background: The burden of ST-segment elevation myocardial infarction (STEMI) worldwide is increasing as the leading cause of death; there are scant data on system-based initiatives and performance metrics relative to its management in low- and middle-income countries where resources are frequently limited.
Objectives: The Global Heart Attack Treatment Initiative (GHATI) ultimate aim is improving evidence-based STEMI care, adherence to guidelines, and tracking of clinical and institutional indicators in low- and middle-income countries. To achieve that goal, the process of care and outcomes of STEMI patients in those nations will be studied.
Am Heart J
December 2024
Department of Cardiology, Kettering General Hospital, United Kingdom.
This review describes and evaluates the representation of women in cardiovascular randomized controlled trials (RCT), it reports significant under-representation of women in clinical trials both as participants and researchers and discusses the ethical implications of under-representation. The under-representation of women as participants in cardiovascular RCTs is evident in trials investigating cardiovascular drugs, acute coronary syndrome, heart failure and interventional procedures and devices. Under-representation of women is also evident in the authorship of cardiovascular clinical trials and in trial leadership roles, and under-representation of women as trial investigators is independently associated with under- recruitment of women as trial participants.
View Article and Find Full Text PDFCan J Cardiol
January 2025
Department of Medicine and of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Medicine and of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Cardiology, Capital Health, Halifax, Nova Scotia, Canada; American College of Cardiology, Atlantic Provinces.
Circ Cardiovasc Qual Outcomes
November 2024
Division of Cardiovascular Disease, Department of Medicine, Cardiovascular Research Institute, Morehouse School of Medicine Chief Diversity Equity and Inclusion Division for ACC, Atlanta, GA. American College of Cardiology, Washington, DC.
Interv Cardiol Clin
January 2025
Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA. Electronic address:
Interv Cardiol Clin
January 2025
Section of General Internal Medicine, Boston University Chobanian and Avedisian School of Medicine, 801 Massachusetts Avenue, Room 2082, Boston, MA 02118, USA; GenderCare Center, Boston Medical Center, 801 Massachusetts Ave. Rm. 2082, Boston, MA, 02118 USA. Electronic address:
Transgender and gender diverse patients undergoing cardiac procedures require unique considerations to ensure the delivery of respectful, safe, and high-value health care. There are several issues for which practicing clinicians may have limited experience managing, including the potential interactions between gender-affirming medical and surgical interventions and cardiovascular conditions; using correct patient name and pronouns and additional strategies to increase comfort and safety of medical interventions; and nuances of cardiac clearance before gender-affirming surgeries. This article provides a primer on these topics and sets cardiologists up to learn more about the needs of transgender and gender diverse patient populations.
View Article and Find Full Text PDFJ Am Coll Cardiol
October 2024
Journal of the American College of Cardiology, Heart House, Washington, DC, USA; Philip R. Lee Institute for Health Policy Studies, University of California-San Francisco, San Francisco, California, USA; Section of Cardiology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
Circ Cardiovasc Interv
October 2024
Scientific Publications Committee, American College of Cardiology, Washington, DC.
J Am Coll Cardiol
December 2024
Division of Vascular Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address:
Circulation
December 2024
Division of Vascular Medicine, University of Texas Southwestern Medical Center, Dallas, TX (J.A.B.).
J Clin Epidemiol
November 2024
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address:
Clin Adv Hematol Oncol
October 2024
Cardio-Oncology Leadership Council, American College of Cardiology, Washington, D.C.
Circ Cardiovasc Qual Outcomes
October 2024
Scientific Publications Committee, American College of Cardiology, Washington, DC.
J Am Coll Cardiol
December 2024
The Lancet, London EC2Y 5AS, United Kingdom.
Lancet
August 2024
The Lancet, London EC2Y 5AS, UK.
J Soc Cardiovasc Angiogr Interv
May 2024
President, American Heart Association.
JACC Adv
July 2024
Chief Diversity, Equity and Inclusion Officer at American College of Cardiology, Morehouse School of Medicine, Atlanta, Georgia, USA.
JACC Adv
July 2024
Department of Cardiology, Medstar Heart and Vascular Institute and Georgetown University, Washington, DC, USA.
Background: The COVID-19 pandemic catalyzed unprecedented changes to medical education, including CV fellowship programs. CV fellowship PDs offer a unique perspective regarding the impact of the pandemic on CV medical education.
Objectives: The 4th annual Cardiovascular Diseases (CV) Fellowship Program Directors (PDs) Survey sought to understand the impact of the COVID-19 pandemic on CV fellows and fellowship programs.
PM R
November 2024
Research Center, Parker University, Dallas, Texas, USA.
Objectives: Patients' interactions with health care providers influence back pain-related outcomes. The Health Care Providers' Pain and Impairment Relationship Scale (HC-PAIRS) is an instrument that assesses providers' attitudes and beliefs about patients with persistent back pain, with lower scores implying that persistent pain does not indicate disability or limitation of activities. This scoping review aims to explore the extent of research involving the HC-PAIRS.
View Article and Find Full Text PDF